Merus N.V. Common Shares

MRUS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
MRUS Income Statement
MRUS Balance Sheet
MRUS Cash Flow
Congress Trading

Recent trades of MRUS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
MRUS Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
MRUS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MRUS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by MRUS's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Corporate Lobbying

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Antibody that binds erbb-2 and erbb-3 Nov. 12, 2024
  • Patent Title: Methods and means for the production of ig-like molecules Oct. 22, 2024
  • Patent Title: Bispecific igg antibodies as t cell engagers Aug. 13, 2024
  • Patent Title: Pd-1 binding domains May. 28, 2024
  • Patent Title: Multivalent antibody Apr. 09, 2024
  • Patent Title: Binding molecules that inhibit cancer growth Mar. 26, 2024
  • Patent Title: Methods and means for the production of ig-like molecules Mar. 12, 2024
  • Patent Title: Antibody producing non-human animals Mar. 12, 2024
  • Patent Title: Clec12axcd3 bispecific antibodies and methods for the treatment of disease Jan. 16, 2024
  • Patent Title: Methods of treating a subject having an egfr-positive and/or erbb-3-positive tumor Nov. 21, 2023
  • Patent Title: Antibody producing non-human animals Oct. 17, 2023
  • Patent Title: Human cd3 binding antibody Aug. 29, 2023
  • Patent Title: Antibodies that modulate a biological activity expressed by a cell Aug. 22, 2023
  • Patent Title: Binding molecules that bind cd137 and pd-l1 Jun. 27, 2023
  • Patent Title: Binding molecules that modulate a biological activity expressed by a cell Jun. 06, 2023
  • Patent Title: Antibody producing non-human animals Jan. 24, 2023
  • Patent Title: Antibody producing non-human animals Sep. 20, 2022
  • Patent Title: Generation of binding molecules Aug. 09, 2022
  • Patent Title: Antibody that binds erbb-2 and erbb-3 Mar. 22, 2022
  • Patent Title: Antibody producing non-human animals Feb. 01, 2022
  • Patent Title: Antibody producing non-human mammals Apr. 06, 2021
  • Patent Title: Recombinant production of mixtures of antibodies Mar. 02, 2021
  • Patent Title: Antibodies that bind egfr and erbb3 Nov. 24, 2020
  • Patent Title: Methods and means for the production of ig-like molecules Aug. 25, 2020
  • Patent Title: Method for selecting a single cell expressing a heterogeneous combination of antibodies Jun. 02, 2020
  • Patent Title: Generation of binding molecules May. 12, 2020
  • Patent Title: Recombinant production of mixtures of antibodies Dec. 17, 2019
  • Patent Title: Bispecific igg antibodies as t cell engagers Jul. 23, 2019
  • Patent Title: Methods and means for the production of ig-like molecules Jul. 02, 2019
  • Patent Title: Methods and means for the production of ig-like molecules Jun. 25, 2019
  • Patent Title: Human cd3 binding antibody Apr. 23, 2019
  • Patent Title: Antibody producing non-human mammals Apr. 24, 2018
  • Patent Title: Antibody producing non-human mammals Apr. 17, 2018
  • Patent Title: Human cd3 binding antibody Mar. 13, 2018
  • Patent Title: Generation of binding molecules Mar. 06, 2018
  • Patent Title: Antibody producing non-human mammals Sep. 19, 2017
  • Patent Title: Methods and means for the production of ig-like molecules Sep. 12, 2017
  • Patent Title: Method for selecting a single cell expressing a heterogeneous combination of antibodies Aug. 22, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of MRUS in WallStreetBets Daily Discussion

MRUS News

Recent insights relating to MRUS

CNBC Recommendations

Recent picks made for MRUS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MRUS

MRUS Top Shareholders
Shareholder
Shares Held
MRUS Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MRUS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MRUS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top